Cancer Biomarkers Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Global

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Diagnostics > Healthcare > Cancer Biomarkers Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Cancer Biomarkers Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Cancer biomarkers are used to trace and indicate the biological state of a tumour and thus analyse diagnostic and prognostic stages of cancer.The market is valued at USD 12.005 Billion in 2017 and is expected to reach USD 23.87 Billion by 2024 at a CAGR of 12.4%.

Cancer Biomarkers market share:

Cancer type segments cancer biomarkers market into breast cancer, lung cancer, colorectal cancer, melanoma, prostate, thyroid etc. over all these breast cancers is holding the most significant share in the market due to the prevalence of breast cancer and awareness about the diagnosis.

Cancer Biomarkers market size:

Geographically, North America is the dominant region globally, and the United States is the primary contributor. Asia-Pacific is expected to be the fastest growing regional market due to the prevalence of cancer in that region.

Cancer Biomarkers market growth:

The primary factors influencing the market growth an increase in awareness among patients and healthcare professionals about the necessity of early diagnostics of malignance’s and rising demand for personalised medicine is anticipated to

Cancer Biomarkers Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

provide the market with significant growth.

Cancer Biomarkers industry analysis:

The cancer biomarkers market is segmented by type, disease, service, application and technologies. From the kind, the market is categorised into protein biomarkers, genetic biomarkers, cell biomarkers, viral biomarkers, carbohydrate biomarkers. By disease, the market is classified into prostate cancer, lung cancer, breast cancer, colorectal cancer and cervical cancer. By service, the market is categorised into sample preparation, assay development, biomarkers validation and testing. By the application, the market is classified into risk assessment, development of molecular diagnostics, disease diagnostics, drug discovery and development. By technologies, the market is categorised into Omics technologies, imaging technologies, cytogenetics, bioinformatics and IVD multivariate index assays.

Cancer Biomarkers Market Outlook:

Cancer biomarkers are into various fields such as drug discovery, development, personalised medicine and diagnostics. Diagnostics is the essential revenue generating application of market relating to factors such as increasing growth of biomarker-based oncology tests with higher sensitivity.

Cancer Biomarkers Market Trends:

Abbott got new FDA labelling for some of its MRI active

You can also purchase parts of this report. Do you want to check out a section wise price list

Cancer Biomarkers Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

devices and announced the acquisition of st.jude medical, Inc. this transaction provides Abbott with expanded opportunities for future growth. Agilent technologies and multiplicon N.V signed an agreement under which Agilent will acquire multiplicon, a leading European diagnostics company.

Cancer Biomarkers Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
HologicInc
Abbott Laboratories
Roche Diagnostics Corp.
Agilent Technologies
Astex Pharmaceuticals

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.